Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI

PHASE2TerminatedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Myocardial Infarction
Interventions
DRUG

placebo

administration of iv bolus prior to angiography

DRUG

PRT060128 Potassium

administration of iv bolus prior to angiography

Trial Locations (31)

17822

Geisinger Medical Center, Danville

20912

Washington Adventist Hospital, Takoma Park

32308

Tallahassee Memorial Medical Center, Tallahassee

37660

The Heart Center, Kingsport

40536

University of Kentucky Hospital, Gill Heart Center, Lexington

45219

Lindner Clinical Trial Center, Cincinnati

48073

William Beaumont Hospital, Royal Oak

48085

William Beaumont Hospital - Troy Cardiology, Troy

48202

Henry Ford Hospital, Detroit

48341

St. Joseph Mercy - Oakland, Pontiac

48439

Genesys Regional Medical Center, Grand Blanc

50314

Iowa Heart Center, Des Moines

04102

Maine Medical Center, Portland

T2N2T9

Foothills Hospital, Calgary

T5H3V7

Royal Alexandria Hospital, Edmonton

T6G2B7

University of Alberta Hospital, Edmonton

V5Z1M9

Vancouver General Hospital, Vancouver

V6Z1Y6

St. Paul's Hospital, Vancouver

V8R4R2

Victoria Heart Institute, Royal Jubilee Hospital, Victoria

E2L4L2

Atlantic Health Services, Saint John

A1B3V6

General Hospital - Heath Sciences Centre, St. John's

B3H3A7

Queen Elizabeth II Health Sciences Centre, Halifax

L8L2X2

Hamilton Health Sciences, Hamilton

N6A5A5

London Health Sciences, London

L5B2P7

Trillium Health Centre - Mississaugua, Mississauga

L3Y2R2

Soutlake Regional Health Centre, Newmarket

M4N3M5

Sunnybrook Health Sciences Centre, Toronto

H1T1C8

Montreal Heart Institute, Montreal

H2W1T8

Centre Hospitalier Universitaire de Montreal - Hotel Dieu, Montreal

H4N1C5

Hospital du Sacre Coeur, Montreal

S4P0W5

Regina General Hospital, Regina

Sponsors
All Listed Sponsors
lead

Portola Pharmaceuticals

INDUSTRY

NCT00546260 - Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI | Biotech Hunter | Biotech Hunter